Endovastec(SH:688016) Sou Hu Cai Jing·2026-01-19 18:47Trading Information - On January 19, 2026, the stock of Xinmai Medical (688016) closed at 96.73 yuan, down 1.28%, with a turnover rate of 1.17% and a trading volume of 14,500 shares, resulting in a transaction amount of 141 million yuan [1]. Fund Flow - On January 19, the net outflow of main funds was 3.67 million yuan, while the net inflow of retail funds was 10.35 million yuan, and the net outflow of individual investors was 6.67 million yuan [1][3]. Company Announcement - Xinmai Medical announced the approval to use up to 1 billion yuan of temporarily idle raised funds for cash management, investing in high-security and high-liquidity products such as structured deposits, notice deposits, fixed-term deposits, large certificates of deposit, and income certificates. The investment period is within 12 months from the date of board approval, and the funds can be rolled over [1]. - The company committed that this action will not affect the normal implementation of the fundraising investment plan, and the income generated will be used to supplement funding shortages for investment projects and daily operational liquidity [1]. - China International Capital Corporation (CICC) provided a review opinion stating that the planned use of idle funds for cash management does not change the purpose of the raised funds, does not affect the normal implementation of investment projects, and is beneficial for improving fund utilization efficiency without harming the interests of the company and its shareholders [1].